Abstract
This review focuses on neutrophils and provides a modern answer to the question: why does the bone marrow release 45 billion neutrophils into the bloodstream every day, where they remain for several hours, then migrate into tissues and die within 24 hours? The review discusses neutrophil death pathways, including apoptosis and NETosis. The architecture of epithelial tissue in the normal state and the changes occurring during tumor growth are presented.
The most appropriate form of neutrophil cell death in malignant neoplasms is apoptosis, because in this case the cellular contents are not released into the extracellular environment and therefore do not provoke inflammation; instead, apoptosis activates innate lymphoid cells and the adaptive arm of the immune response.
One of the functions of the immune system is to maintain homeostasis of both lymphoid and non-lymphoid tissues of the macroorganism. During tumor growth, two competing programs of development and repair coexist: those of normal tissue and tumor tissue.
In malignant disease, both mononuclear cells and neutrophils are overloaded with double-stranded nucleic acids. This may interfere with their ability to cross the blood-tissue barrier.
The effect of chemotherapy in malignant neoplasms is mediated not only by the direct impact of cytotoxic drugs on malignant cells, but also by their influence on neutrophils, which — through an avalanche of apoptotic bodies — activate both innate and adaptive immunity, thereby restoring damaged tissue architecture.
References
2. Исследование системы крови в клинической практике. Ред. Г. И. Козинец. М.: Триада Х; 1998. 480 с.
3. Кайряк О. В. Сенсибилизация лейкоцитов к антигенам опухоли и нормальной слизистой у больных раком желудка. Тезисы докладов 8 съезда онкологов УССР. 1990; 548–9.
4. Кайряк О. В. Содержание нуклеиновых кислот в лейкоцитах периферической крови и сыворотке у больных солидными опухолями при проведении эндолимфатической химиотерапии. Архив клинической и экспериментальной медицины. 2000; 9(4): 504–7.
5. Кайряк О. В., Лисовская Н. Ю., Фролов А. К. и др. Возможная роль иммунной системы в контроле пролиферации и дифференцировки при опухолевом росте. Достижения и проблемы генетики, селекции и биотехнологии: сборник научных работ. 2007; 451–4.
6. Кайряк О. В., Семикоз Н. Г., Лисовская Н. Ю. и др. Апоптотические тельца как переносчики химиопрепаратов в опухолевую ткань. Новообразования. 2007; 2: 129–35.
7. Кайряк О. В., Лисовская Н. Ю., Семикоз Н. Г. Частота спонтанного апоптоза в лимфоцитах периферической крови опухоленосителей как критерий прогнозирования эффективности специального лечения. Цитология и генетика. 1999; 33(2): 23–6.
8. Файнштейн Ф. Э., Козинец Г. И., Бахрамов С. М. и др. Болезни системы крови. Ташкент: Медицина УзССР. 1987. 671 с.
9. Aegerter H., Lambrecht B. N., Jakubzick C. V. Biology of lung macrophages in health and disease. Immunity. 2022; 55(9): 1564–80. https://doi.org/10.1016/j.immuni.2022.08.010.
10. Anker P., Stroun M., Maurice P. A spontaneous release of DNA by human blood lymphocytes in vitro. Cancer Res. 1975; 35: 2375–8.
11. Fournie G. J., Courtin J. P., Laval F. et al. Plazma DNA as a marker of cancerous cell death. Investigations in patient suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett. 1995; 91: 221–7.
12. Furze R. C., Rankin S. M. The role of the bone marrow in neutrophil clearance under homeostatic conditions in the mouse. FASEB J. 2008; 22: 3111–9. https://doi.org/10.1096/fj.08-109876.
13. Mehrotra P., Ravichandran K. S. Drugging the efferocytosis process: concept and opportunities. Nat Rev Drug Discov. 2022; 21(8): 601–20. https://doi.org/10.1038/s41573-022-00470-y.
14. Nadeau A., Tsering Th., Abdouh M. et al. Characterization of extracellular vesicle-associated DNA and proteins derived from organotropic metastatic breast cancer cells. J Exp Clin Cancer Res. 2025; 44: 157. https://doi.org/10.1186/s13046-025-03418-3.
15. Kerr J. F., Wyllie A. H., Currie A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972; 26: 239–57. https://doi.org/10.1038/bjc.1972.33
16. Kerr J. F. R. History of the events leading to the formulation of the apoptosis concept. Toxicology. 2002; 181–182: 471–4.
17. Li J., Xiao C., Li C. et al. Tissue-resident immune cells: from defining characteristics to roles in diseases. Signal Transduct Target Ther. 2025; 10: 12. https://doi.org/10.1038/s41392-024-02050-5.
18. Ocana A., Nieto-Jiménez C., Pandiella A. et al. Neutrophils in cancer: prognostic role and therapeutic strategies. Mol Cancer. 2017; 16: 137. https://doi.org/10.1186/s12943-017-0707-7.
19. Park W., Wei Sh., Kim Bo-S. et al. Diversity and complexity of cell death: a historical review. Exp Mol Med. 2023; 55(8): 1573–94. https://doi.org/10.1038/s12276-023-01078-x.
20. Shapiro B., Chakralorti M., Cohn E. M. et al. Determination of circulation DNA level in patients with benign or malignant gastrointestinal disease. Cancer. 1983; 51: 2116–20.
21. Schedel F., Mayer-Hain S., Pappelbaum K. I. et al. Evidence and impact of neutrophil extracellular traps in malignant melanoma. Pigment Cell Melanoma Res. 2020; 33: 63–73. https://doi.org/10.1111/pcmr.12818.
22. Tu H., Ren H., Jiang J. et al. Dying to defend: Neutrophil death pathways and their implications in immunity. Adv Sci (Weinh). 2024; 11(8): e2306457. doi:10.1002/advs.202306457.
23. Wang X., Cai J., Lin B. et al. GPR34-mediated sensing of lysophosphatidylserine released by apoptotic neutrophils activates type 3 innate lymphoid cells to mediate tissue repair. Immunity. 2021; 54: 1123–36.
24. Wang Y., Yang K., Li J. et al. Neutrophil extracellular traps in cancer: From mechanisms to treatments. Clin Transl Med. 2025; 15: e70368. https://doi.org/10.1002/ctm2.70368.
25. Wahnou H., Kebbaj R., Hba S. et al. Neutrophils and Neutrophil-Based Drug Delivery Systems in Anti-Cancer Therapy. Cancers. 2025; 17(7): 1232. https://doi.org/10.3390/cancers17071232.
26. Withers D. R. Innate lymphoid cell regulation of adaptive immunity. Immunology. 2016; 149(2): 123–30. https://doi.org/10.1111/imm.12639.